Cargando…
Prolonged and Substantial Discordance in Prevalence of Raltegravir-Resistant HIV-1 in Plasma versus PBMC Samples Revealed by 454 “Deep” Sequencing
The evolution of drug resistance mutations in plasma samples is relatively well-characterized. However, the viral population and diversity in other body compartments such as peripheral blood mononuclear cells (PBMC) remains poorly understood. Previous studies have mostly focused on protease and reve...
Autores principales: | Lee, Guinevere Q., Swenson, Luke C., Poon, Art F. Y., Martin, Jeffrey N., Hatano, Hiroyu, Deeks, Steven G., Harrigan, P. Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458959/ https://www.ncbi.nlm.nih.gov/pubmed/23049972 http://dx.doi.org/10.1371/journal.pone.0046181 |
Ejemplares similares
-
“Deep” Sequencing Accuracy and Reproducibility Using Roche/454 Technology for Inferring Co-Receptor Usage in HIV-1
por: Knapp, David J. H. F., et al.
Publicado: (2014) -
Comparison of Illumina and 454 Deep Sequencing in Participants Failing Raltegravir-Based Antiretroviral Therapy
por: Li, Jonathan Z., et al.
Publicado: (2014) -
Raltegravir monohydrate
por: Yamuna, Thammarse S., et al.
Publicado: (2013) -
HIV resistance to raltegravir
por: Clavel, François
Publicado: (2009) -
Theoretical and experimental assessment of degenerate primer tagging in ultra-deep applications of next-generation sequencing
por: Liang, Richard H., et al.
Publicado: (2014)